Study weighs risks and benefits of phase I trials in pediatric cancer
On average, 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-related complications, according to a new systematic review and meta-analysis published this ...
Feb 20, 2018
0
2